Loading...

Donald Easton, MD

TitleProfessor
InstitutionUniversity of California San Francisco
DepartmentNeurology
Address675 Nelson Rising Lane
San Francisco CA 94158
Phone415-502-7329
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    New York Hospital-Cornell Medical CenterIntern1965Medicine
    University of WashingtonMD1964School of Medicine
    New York Hospital-Cornell Medical CenterResidency1968Neurology
    Washington State UniversityBS1960Zoology

    Collapse Overview 
    Collapse Overview
    J. Donald Easton, MD, was born in Saskatoon, Saskatchewan, Canada. He graduated with honors from the University of Washington School of Medicine and was elected to membership in Phi Beta Kappa and Alpha Omega Alpha. Dr. Easton completed his internship in medicine and residency in neurology at the New York Hospital-Cornell Medical Center and assumed his first academic appointment at the University of California at San Diego. In 1986 he was appointed Professor and Chair of the Department of Clinical Neurosciences at the Rhode Island Hospital and Alpert Medical School of Brown University. In January 2010 Dr. Easton joined our faculty in the Department of Neurology at UCSF to work with Dr. Clay Johnston on his NIH-funded POINT (Platelet-Oriented Inhibition in New TIA and minor ischemic stroke) trial.

    Dr. Easton has been a Director of the American Board of Psychiatry & Neurology, a Councilor of the American Neurological Association, an officer of the Association of University Professors of Neurology, Chairman of the Residency Review Committee for Neurology, Chairman of the American Heart Association Stroke Council, Chairman of the Neurological Disorders Program, Project Review Committee-A at the NIH, and a member of the NIH Advisory Council for the Neurological Institute.

    Dr. Easton has served on numerous Steering, Advisory, Organizing and Monitoring Committees for many clinical trials and congresses. He also has served on the editorial boards of many journals. He has published more than 300 journal articles, books, chapters & miscellaneous publications.

    He is an honorary member of the Stroke Society of Australasia, the Austrian Society for Stroke Research, the Belgian Stroke Society, the Brazilian Society of Cerebrovascular Diseases and the Mexican Association of Cerebral Vascular Disease.


    Collapse Research 
    Collapse Research Activities and Funding
    POINT: PLATELET-ORIENTED INHIBITION IN NEW TIA
    NIH/NINDS U01NS062835Sep 30, 2009 - Apr 30, 2021
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Easton D, Aunes M, Albers GW, Amarenco P, Bokelund-Singh S, Denison H, Evans SR, Held P, Jahreskog M, Jonasson J, Minematsu K, Molina CA, Wang Y, Wong KSL, Johnston SC. Risk for Major Bleeding in Patients Receiving Ticagrelor Compared With Aspirin After Transient Ischemic Attack or Acute Ischemic Stroke in the SOCRATES Study (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes). Circulation. 2017 Sep 05; 136(10):907-916. PMID: 28655834.
      View in: PubMed
    2. Weber M, Bhatt DL, Brennan DM, Hankey GJ, Steinhubl SR, Johnston SC, Montalescot G, Mak KH, Fox KA, Easton D, Topol EJ, Hamm CW. High-sensitivity C-reactive protein and clopidogrel treatment in patients at high risk of cardiovascular events: a substudy from the CHARISMA trial. Heart. 2011 Apr; 97(8):626-31. PMID: 21393433.
      View in: PubMed
    3. Topol EJ, Easton D, Harrington RA, Amarenco P, Califf RM, Graffagnino C, Davis S, Diener HC, Ferguson J, Fitzgerald D, Granett J, Shuaib A, Koudstaal PJ, Theroux P, Van de Werf F, Sigmon K, Pieper K, Vallee M, Willerson JT. Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease. Circulation. 2003 Jul 29; 108(4):399-406. PMID: 12874182.
      View in: PubMed
    Donald's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Related Authors
    People who share related concepts with this person.
    _